Bruker (BRKR) EBT (2010 - 2026)

Bruker's EBT history runs 17 years deep, the most recent figure standing at $21.9 million for Q1 2026.

• Quarterly EBT fell 12.75% year-over-year to $21.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$196.2 million (down 2.29% YoY) and the FY2025 annual result came in at -$317.9 million, down 180.09% from the prior year.
• EBT was $21.9 million for Q1 2026 at Bruker, up from -$271.7 million in the prior quarter.
• Across five years, EBT topped out at $240.2 million in Q4 2023 and bottomed at -$306.2 million in Q4 2022.
• A 5-year average of -$2.4 million and a median of $49.9 million in 2022 frame the typical range for EBT.
• Peak annual rise in EBT reached 207.44% in 2022, while the deepest fall reached 4739.39% in 2022.
• Bruker's EBT stood at -$306.2 million in 2022, then soared by 178.45% to $240.2 million in 2023, then slumped by 210.03% to -$264.3 million in 2024, then retreated by 2.8% to -$271.7 million in 2025, then soared by 108.06% to $21.9 million in 2026.
• Business Quant data shows BRKR's EBT at $21.9 million in Q1 2026, -$271.7 million in Q4 2025, and $59.6 million in Q3 2025.